| Trial | AHEAD-MERIT (BNT113) |
|---|---|
| Cancer Type | Head & Neck Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | An open-label Phase II randomized trial of BNT113 in combination with pembrolizumab versus pembrolizumab monotherapy as a first line therapy in patients with unresectable recurrent, or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) which is positive for human papilloma virus 16 (HPV16+) and expresses PD-L1 |
| Trial Open | Yes |
 |
Click Here to view trial summary |
| Trial | iNATT |
|---|---|
| Cancer Type | Head & Neck Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | The interNational Anaplastic Thyroid Cancer Tissue Bank and Database Project |
| Trial Open | Yes |
| Trial | ModiFY Study |
|---|---|
| Cancer Type | Head & Neck Cancer, Kidney Cancer, and Ovarian Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | The ModiFY Study: A phase 1/2, multicentre, open‐label study of Modi‐1 in patients with breast, head and neck, ovarian, or renal cancer |
| Trial Open | Yes |